TO4. Clinical coordinating center for nida's clinical trials network. Contract type: IDIQ task order. POP: 8/15/24 - 8/14/29
Ended Awarded Last action
- Contract number
- 75N95025F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,656,081
Award facts
- Opportunity
-
- TORFP4 Solicitation number
- Contract value 100% obligated
- $4,656,081.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $4,656,081.38 cost-plus-fixed-fee delivery order contract awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA), a civilian agency, to serve as the Clinical Coordinating Center for NIDA's Clinical Trials Network. The five-year contract, which runs from August 15, 2024, to August 14, 2029, does not have a set-aside designation.
The Emmes Company LLC is a global clinical research organization that provides comprehensive research support services to federal agencies, particularly within the National Institutes of Health (NIH). Under this contract, Emmes will be responsible for coordinating the clinical trials conducted through NIDA's Clinical Trials Network, which focuses on substance abuse research. Emmes has a strong track record of securing federal contract awards and grants from various NIH institutes, demonstrating its expertise in delivering biostatistical, epidemiological, data management, clinical trial coordination, and regulatory support for complex biomedical research initiatives.
Quick answers
Who was awarded contract 75N95025F00001?
75N95025F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on July 16, 2025.
How much is contract 75N95025F00001 worth?
The government has obligated $4,656,081 on 75N95025F00001.
Is contract 75N95025F00001 an order under another contract?
Yes. 75N95025F00001 is a delivery order under 75N95024D00037, an indefinite delivery contract.
Was contract 75N95025F00001 competed?
The extent of competition for 75N95025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award